AI Tools Matthew Kurian: FDA Clears AI Tool to Predict Breast Cancer Recurrence Risk Before SurgeryBy AdminBitOctober 18, 20260 “TumorSight Risk recently received FDA 510(k) clearance, marking another step forward for AI in breast oncology.
